Velcade indicated in mantle cell lymphoma

The antineoplastic agent is also indicated in the treatment of multiple myeloma  | SCIENCE PHOTO LIBRARY
The antineoplastic agent is also indicated in the treatment of multiple myeloma | SCIENCE PHOTO LIBRARY
Velcade (bortezomib) can now be used, in combination with rituximab, cyclophosphamide, doxorubicin and prednisolone, for the treatment of adults with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation. 
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

MIMS launches Respiratory and Allergy Learning workshops 2019

MIMS launches Respiratory and Allergy Learning workshops 2019

Join us for the MIMS Workshops Respiratory and Allergy...

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests
Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.